Title : A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women.

Pub. Date : 2022 Mar 14

PMID : 35022783






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We tested the efficacy of the dual orexin receptor antagonist suvorexant for chronic insomnia related to nighttime VMS. suvorexant hypocretin neuropeptide precursor Homo sapiens